Lakefront Biotherapeutics (LKFT)

Nasdaq: LKFT · Pharmaceutical Preparations · 2800 Mechelen, BE · filing with the SEC since 2007

Grade7.0

◀ Past 6.6● Present 7.7▶ Future 6.6

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In thousands of euros (EUR), as filed; per-share figures in euros; share counts in thousands.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Report filed	Mar 26, 2026	Mar 27, 2025	Mar 28, 2024	Mar 23, 2023	Mar 24, 2022	Mar 25, 2021	Mar 27, 2020	Mar 29, 2019	Mar 23, 2018	Mar 23, 2017
Revenue	1,112,248	275,649	239,724	241,249^r	234,384^r	478,053	834,901^r	278,666^r	127,087	129,519
Cost of revenue	29,736	34,863	·	12,079	1,629	·	·	·	·	·
Research and development	459,421	335,459	241,294	269,797^r	320,503^r	523,667	420,090^r	316,222^r	218,502	139,573
Sales and marketing	6,100	17,193	5,676	3,480^r	3,776^r	66,468	24,577	4,146	2,803	1,785
General and administrative	147,333	117,245	128,289	135,155^r	127,744^r	118,757	72,382^r	34,377^r	24,415	21,744
Total operating expenses	·	·	·	·	·	708,892	517,049^r	354,746^r	245,720	163,103
Operating income	295,039	-188,338	-88,263	-131,056^r	-171,568^r	-178,632	368,748^r	-47,080^r	-89,802	-11,491
Finance costs	1,034	911	1,770	6,884^r	11,592^r	9,389	1,268^r	780	936	47
Interest income	46,339	89,378	79,290	18,094	·	·	·	·	·	·
Net finance income (costs)	·	·	·	·	·	·	-220,233	15,598	-25,705	65,737
Income before income taxes	300,871	-3,085	5,625	-70,849^r	-119,402^r	-309,775	148,525^r	-31,417^r	-115,507	54,246
Income tax expense	-18,621	-1,803	9,613	572^r	1,389^r	1,226	-165^r	822^r	198	235
Income from continuing operations	319,492	-1,282	-3,988	-71,421^r	-120,791^r	-311,001	148,689	-32,240	·	·
Income from discontinued operations	1,392	75,364	215,685	-146,570	17,560^r	5,565	1,156	2,981	·	·
Net income	320,884	74,082	211,697	-217,991	-103,231	-305,436	149,845	-29,259	-115,704	54,012
Net income to shareholders	320,884	74,082	211,697	-217,991	-103,231	-305,436	149,845	-29,259	-115,704	54,012
Net income to ordinary shareholders	320,884	74,082	211,697	-217,991	-103,231	-305,436	149,845	-29,259	-115,704	54,012
Earnings per share, basic	4.87	1.12	3.21	-3.32	-1.58	-4.69	2.60	-0.56	-2.34	1.18
Earnings per share, diluted	4.87	1.12	3.21	-3.32	-1.58	-4.69	2.49	-0.56	-2.34	1.14
Weighted average shares, basic	65,897	65,897	65,884	65,699	65,500	65,075^r	57,614	52,113^rb	49,479	45,696
Weighted average shares, diluted	65,897	65,897	65,884	65,699	·	·	·	52,113	49,479	47,308

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it soldifrs-full:Revenue

Cost of revenue what it cost to make or buy what it soldifrs-full:CostOfSales

Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense

Sales and marketing the cost of finding and serving customersifrs-full:SalesAndMarketingExpense

General and administrative the cost of running the company itselfifrs-full:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherifrs-full:OperatingExpense

Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities

Finance costs what its borrowing costifrs-full:InterestExpense

Interest income what its cash and investments earnedifrs-full:RevenueFromInterest

Net finance income (costs) interest earned less interest paid, outside the businessifrs-full:FinanceIncomeCost

Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax

Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations

Income from continuing operations profit from the businesses it keepsifrs-full:ProfitLossFromContinuingOperations

Income from discontinued operations profit or loss from businesses it sold or closedifrs-full:ProfitLossFromDiscontinuedOperations

Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss

Net income to shareholders the profit or loss that belongs to the company's shareholdersifrs-full:ProfitLossAttributableToOwnersOfParent

Net income to ordinary shareholders what is left for common shareholdersifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity

Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare

Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare

Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares

Weighted average shares, diluted the average count with every share that could be issuedifrs-full:AdjustedWeightedAverageShares

SI Assistanton LKFT · research, not advice